3Varms S,Wilson H,Kurwa A,et a1. Bowen's disease,so-lar keratoses and superficial basal cell carcinomas treatedby photod)rnamic therapy using a large field incoherent lightsource[J].British Journal of Dermatology,2001,(03):567-574.
6[36]Vrouenraets MB,Visser GW,Stigter M,et al.Targeting of aluminum (Ⅲ) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies:improved efficacy in photodynamic therapy[J].Cancer Res,2001,61:1970-1975.
7[1]Castano AP,Demidova TN,Hamblin MR.Mechanisms in photodynamic therapy.Part one.Photosensitizers,photochemistry and cellular localization[J].Photodiagn Photodyn Ther,2004,1:279-293.
8[2]Castano AP,Demidova TN,Hamblin MR.Mechanisms in photodynamic therapy.Part two.Cellular signaling,cell metabolism and modes of cell death[J].Photodiagn Photodyn Ther,2005,2:1-23.
9[3]Castano AP,Demidova TN,Hamblin MR.Mechanisms in photodynamic therapy.Part three.Photosensitizer pharmacokinetics,biodistribution,tumor localization and modes of tumor destruction[J].Photodiagn Photodyn Ther,2005,2:91-106.
10[4]Elmets CA,Bowen KD.Immunological suppression in mice treated with hematoporphyrin derivative photoradiation[J].Cancer Res,1986,46:1608-1611.
